BioSapien

BioSapien is a venture capital-backed biotechnology company focused on innovative therapies to transform patient care. The company has developed MediChip™, a novel 3D-printed biodegradable mesh that delivers drugs locally and continuously for cancer indications while reducing systemic side effects. MediChip’s flexible properties primarily target tumor cells and hard-to-reach tumor sites by directly delivering anticancer drugs to the tumor site. The 3D-printed biodegradable mesh is designed to deliver FDA-approved drugs more accurately without adverse effects.